This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Stock Moves -0.02%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $478.14 in the latest trading session, marking a -0.02% move from the prior day.
The Zacks Analyst Blog Highlights: UNH, PG, CVS, SQ, and ABB
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UNH, PG, CVS, SQ, and ABB.
Why Retaining Cigna (CI) Stock for Now is a Prudent Move?
by Zacks Equity Research
Cigna (CI) expects growth of at least 350,000 customers in 2021 to ramp up total medical clients.
Centene (CNC) Up 4.8% on Upbeat '22 Guidance: Key Details
by Zacks Equity Research
Centene (CNC) expects bottom-line growth to be supported by lower expenses and gross margin improvement.
UnitedHealth's (UNH) Arms Receive Rating Actions From AM Best
by Zacks Equity Research
UnitedHealth's (UNH) subsidiaries get rating upgrades from AM Best. Moreover, outlook of the ratings is revised to stable.
Top Analyst Reports for UnitedHealth, Procter & Gamble & CVS
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Procter & Gamble Company (PG), and CVS Health Corporation (CVS).
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $464.73 in the latest trading session, marking a +1% move from the prior day.
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PFM
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network (Revised)
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
UnitedHealth (UNH) Unit Launches Plan, Boosts Arizona Presence
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary UnitedHealthcare unveils The Doctors Plan of Arizona that will offer high-quality and affordable care for two counties in Arizona.
Humana (HUM) Ties Up to Enhance Medicare Advantage Business
by Zacks Equity Research
Humana (HUM) forges an alliance with the Loudoun Medical Group to boost its Medicare Advantage portfolio.
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
UnitedHealth (UNH) Ups Guidance: Here's What You Should Know
by Zacks Equity Research
UnitedHealth's (UNH) 2022 bottom line estimates are below the Zacks Consensus Estimate, may be due to an uptick in insurance claims triggered by the coronavirus pandemic.
UnitedHealth Group (UNH) Stock Moves -1.72%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $444.22 in the latest trading session, marking a -1.72% move from the prior day.
UnitedHealth (UNH) Extends Plan Coverage in Massachusetts
by Zacks Equity Research
UnitedHealth Group's unit (UNH) provides an integrated health benefit plan in a bid to offer better health outcomes for eligible members in Massachusetts, who qualify for both Medicare and MassHealth.
Humana (HUM) to Provide Value-Based Care in Central Kansas
by Zacks Equity Research
Humana (HUM) expands the value-based agreement with Hutchinson Clinic in a bid to provide enhanced healthcare services to its MA members in central Kansas.
Humana (HUM) Ties Up With Allina Health to Boost Value-Based Care
by Zacks Equity Research
Humana (HUM) expands value-based agreement with Allina Health, which is aimed at offering enhanced outcomes for HUM's MA members in Minnesota.
Tenet Healthcare (THC) and USPI Strike SurgeryCenter Deal
by Zacks Equity Research
Tenet Healthcare (THC) along with its subsidiary to acquire SurgCenter Development (SCD) for $1.2 billion.
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
Humana's (HUM) Earnings Beat Estimates in Q3, Surge Y/Y
by Zacks Equity Research
Humana's (HUM) Q3 results reflect a better revenue stream and strength in its Retail and Healthcare Services segments.
Cigna (CI) to Post Earnings in Q3: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) Q3 results are likely to reflect growth in earnings and revenues.
Zacks Value Trader Highlights: UnitedHealth, Union Pacific, Home Depot, Ross Stores and JPMorgan
by Zacks Equity Research
Zacks Value Trader Highlights: UnitedHealth, Union Pacific, Home Depot, Ross Stores and JPMorgan
UnitedHealth Group (UNH) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH